戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 activating phosphorylation by Mst1, a serine/threonine kinase.
2 epends on the RTKs activating the AKT serine/threonine kinase.
3  segment conformation of tyrosine and serine/threonine kinases.
4  the protein kinase D (PKD) family of serine/threonine kinases.
5 rylation at Ser133 by various protein serine/threonine kinases.
6  phytochromes are autophosphorylating serine/threonine kinases.
7 amino acid sequences of human protein-serine/threonine kinases.
8 clins associate with cyclin-dependent serine/threonine kinase 1 (CDK1) to generate the M phase-promot
9                Microtubule-associated serine/threonine kinase 1 (MAST1) is a central driver of cispla
10 ric inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK-1).
11 uired caspase-8, receptor-interacting serine/threonine kinase 1 (RIPK1), and Fas-associated death dom
12 -activated protein kinase interacting serine/threonine kinase 1 activation significantly suppresses T
13 educed levels of receptor-interacting serine-threonine kinase 1 and CRC cell necroptosis.
14  lower levels of receptor-interacting serine-threonine kinase 1 and shorter survival times of patient
15 ivated protein kinase and phospho-AKT serine/threonine kinase 1 signaling pathways, as well as increa
16  Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) expression, and miR-155-5p inhibitio
17 in kinase) and MNK1 (MAPK-interacting serine/threonine kinase 1) signaling.
18 TBK1 (TANK-Binding Kinase 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3
19 ed levels of the receptor-interacting serine-threonine kinase 1, a mediator of necroptosis, in CRC ce
20 fibroblasts from receptor interacting serine/threonine kinase 1-knockout mice or their WT littermates
21 te-oriented kinase (LOK), also called serine threonine kinase 10 (STK10), is synthesized mainly in ly
22                  The tumor suppressor serine/threonine kinase 11 (LKB1/STK11) is one of the most freq
23                  The tumor suppressor serine/threonine kinase 11 (STK11 or LKB1) is mutated in 20-30%
24 Liver kinase B1 (LKB1), also known as serine/threonine kinase 11 (STK11) is the major energy sensor f
25                                       Serine/threonine kinase 11 (STK11, also known as LKB1) function
26  (LKB1) tumor suppressor gene, Stk11 (serine threonine kinase 11), in the fetal Mullerian duct mesenc
27  Liver kinase B1 (LKB1, also known as serine/threonine kinase 11, STK11) is a tumor suppressor mutate
28 containing (Nod)/receptor-interacting serine-threonine kinase 2 (Ripk2) signals in DCs.
29 sregulation of microtubule-associated serine/threonine kinase 2 and protein-o-mannose kinase SGK196 i
30 mediated through receptor-interacting serine/threonine kinase 2, and the transcriptional regulator CC
31 ed in TGF-beta signaling, such as AKT Serine/Threonine Kinase 3 (AKT3) and Sulfatase 1 (SULF1).
32 and in vivo by microtubule-associated serine/threonine kinase 3 (MAST3 kinase), an enzyme of previous
33 cally depends on receptor-interacting serine-threonine kinase 3 (RIPK3) and mixed lineage kinase doma
34 ice deficient in receptor-interacting serine-threonine kinase 3 (RIPK3).
35  -12, and -8 and receptor interacting serine/threonine kinase 3 (RIPK3).
36                We also validated that serine/threonine kinase 35 is a target of miR-377 using a dual
37 lin-1) by RIPK4 (receptor-interacting serine-threonine kinase 4) during epidermal differentiation.
38      We identified GCK-1, a conserved serine/threonine kinase [8], as a putative novel anillin intera
39 KD2) is a member of the PKD family of serine/threonine kinases, a subfamily of the CAMK super-family.
40 ted that IkappaB kinase beta is a key serine/threonine kinase activated by autophagy stimuli and that
41 ng protein kinase (HIPK) 2, a nuclear serine/threonine kinase, activates CREB through Ser271 phosphor
42 cificity kinase and both tyrosine and serine/threonine kinase activities are required for its functio
43                                  Pak2 serine/threonine kinase activity is required for stromal-derive
44 terms protein kinase activity/protein serine threonine kinase activity, response to heat and reactive
45         The p.E80K mutation abolished serine/threonine kinase activity, resulting in altered ICK subc
46 , including the regulation of protein serine/threonine kinase activity.
47 mice lacking specific isoforms of the serine/threonine kinase AKT and bone marrow chimeras, we found
48 hosphatidylinositol-3-OH kinase), the serine-threonine kinase Akt and the metabolic checkpoint kinase
49 ied a signaling pathway-involving the serine-threonine kinase AKT and the transcription factor XBP1s,
50       Pharmacologic inhibition of the serine/threonine kinase Akt has recently been shown to promote
51          Although the role of the key serine/threonine kinase Akt in promoting CNS myelination has be
52      Here we examined the role of the serine/threonine kinase Akt in the generation of protective imm
53                                   The serine/threonine kinase AKT is a key mediator of cancer cell su
54                                   The serine-threonine kinase Akt is a key regulator of cell prolifer
55    In response to growth factors, the serine/threonine kinase AKT phosphorylates Thr(24) and Ser(256)
56                                   The serine/threonine kinase Akt plays a central role in cell prolif
57                     Activation of the serine-threonine kinase Akt promotes the survival and prolifera
58                                   The serine-threonine kinase AKT regulates proliferation and surviva
59 ckpoint kinase complex mTORC2 and the serine-threonine kinase Akt, and loss of this activity restores
60 depends on the activation of PI3K and serine-threonine kinase Akt, and protein synthesis relies on th
61                                   The serine/threonine kinase Akt, which regulates HTT function, resc
62 phate (PIP3), and the activity of the serine/threonine kinase AKT.
63 nhibitor of all three isoforms of the serine/threonine kinase AKT.
64 activation-induced phosphorylation of serine-threonine kinases Akt and mechanistic target of rapamyci
65                   This results in AKT serine/threonine kinase (Akt) activation, membrane focal adhesi
66  phosphoinositide 3-kinase (PI3K)/Akt serine/threonine kinase (Akt) and mitogen-activated protein kin
67              Akt is a family of three serine-threonine kinases, Akt1, Akt2, and Akt3.
68  has led to the identification of the serine/threonine kinase ALK2 as a potential target for therapeu
69                             LKB1 is a serine/threonine kinase and a commonly mutated gene in lung ade
70 se (NLK) is an evolutionary conserved serine/threonine kinase and a negative regulator of the Wnt sig
71      Here we show that SPA1 acts as a serine/threonine kinase and directly phosphorylates PIF1 in vit
72 ion of general control nonrepressed 2 serine/threonine kinase and increased expression of mammalian t
73 ion of general control nonrepressed 2 serine/threonine kinase and mammalian target of rapamycin (both
74 focus on coordination of postsynaptic serine/threonine kinase and phosphatase signaling by scaffold p
75  downstream signaling through the ERK serine/threonine kinase and the Fos transcription factor, there
76       The liver kinase B1 (LKB1) is a serine/threonine kinase and tumor suppressor that couples bioen
77 ATIONALE: LKB1 (liver kinase B1) is a serine/threonine kinase and tumor suppressor, which regulates t
78                                   The serine/threonine kinases and sole phosphatase of Mtb tune phosp
79 y ataxia telangiectasia mutated (ATM) serine/threonine kinase, and this phosphorylation is required f
80  expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional
81   We show that the apically localized serine/threonine kinase aPKC directly phosphorylates an N-termi
82 ify CDK5, a predominantly cytoplasmic serine/threonine kinase, as an important regulator of DLC1 func
83 ous to penicillin-binding protein and serine/threonine kinase associated (PASTA) domains, and binds f
84 llular penicillin-binding-protein and serine/threonine kinase-associated (PASTA) domains which bind m
85 terial Penicillin-binding-protein And Serine/Threonine kinase-Associated (PASTA) kinases is of partic
86 ent cations and contains a functional serine/threonine kinase at its carboxyl terminus.
87 1 is phosphorylated by the DNA damage serine/threonine kinase ATM, resulting in increased levels of F
88 led to reduced phosphorylation of the serine/threonine kinases ATM and Chk2 and of histone H2AX after
89 rations in FA-complex genes or in ATM serine/threonine kinase (ATM) exhibited significantly longer tr
90 ment of ataxia-telangiectasia mutated serine/threonine kinase (ATM) to the damaged site, where it pla
91 ion of Gene 33 triggers DDR in an ATM serine/threonine kinase (ATM)-dependent fashion and through pat
92              Classically defined as a serine/threonine kinase, BIK1 is shown here to possess tyrosine
93                      Mutations in the serine/threonine kinase BRAF are found in more than 60% of mela
94 ement within the RAS/ERK pathway, the serine/threonine kinase BRAF plays a key role in development an
95              The B-Raf proto-oncogene serine/threonine kinase (BRAF) gene is the most frequently muta
96  protein kinase B-Raf proto-oncogene, serine/threonine kinase (BRAF) is an oncogenic driver and thera
97 henotype (CIMP), B-Raf proto-oncogene serine/threonine kinase (BRAF) mutation, and Kirsten rat sarcom
98 ability, and the B-Raf protooncogene, serine/threonine kinase (BRAF), mutation) in the Nurses' Health
99  as PLK1 (Polo-like kinase 1), C-MYC, serine-threonine kinase BUB1B and regulates their expression.
100 nd protein phosphatase-1, as well the serine/threonine kinases CaMKII and PKA.
101 ivity is controlled by the Pkn8/Pkn14 serine/threonine kinase cascade, which phosphorylates MrpC on t
102     Here we report that the conserved serine/threonine kinase, casein kinase II (CK2), promotes miRIS
103 aining both an ion channel pore and a serine/threonine kinase (chanzyme).
104 e 7-amino acid truncation in NUAK2, a serine/threonine kinase, completely abrogated its catalytic act
105               Protein kinase CK2 is a serine/threonine kinase composed of two catalytic subunits (CK2
106 tion of their primary sequences, many serine-threonine kinases display a significant preference for s
107                                 A key serine/threonine kinase distantly related to the MAPK family is
108 ate 1970s, is composed of at least 10 serine/threonine kinases, divided into three groups based on th
109 apoptotic gene FASTKD2 (fas-activated serine/threonine kinase domains 2; rs7594645-G) with better mem
110 tivated kinases (PAK) are a family of serine/threonine kinases downstream of multiple critical tumori
111      p21-activated kinases (PAKs) are serine/threonine kinase effectors of the small GTPases Rac and
112 nase 1 (DCLK1), a microtubule binding serine threonine kinase, emerged as a promising target due to i
113  show that the kinase activity of the serine/threonine kinase encoded by TAOK2 is required for spine
114   The Escherichia coli eukaryote-like serine/threonine kinase, encoded by yeaG, is expressed in respo
115 , we find that phosphorylation of the serine/threonine kinase ERK (pERK) preferentially occurs in end
116 well appreciated that eukaryotic-like serine/threonine kinases (eSTKs) control essential processes in
117 sactivation of microtubule associated serine/threonine kinase family member 4 (MAST4).
118 cting NEK2, a member of the NIMA-like serine-threonine kinase family, in a patient with congenital he
119                     The Fas-activated serine/threonine kinase (FASTK) family of proteins has recently
120 tein kinase C constitutes a family of serine-threonine kinases found in all eukaryotes and implicated
121 arget of rapamycin complex 1 (mTORC1) serine/threonine kinase from the lysosomal membrane.
122           Somatic inactivation of the serine/threonine kinase gene STK11/LKB1/PAR-4 occurs in a varie
123  in vitro functional studies, a novel serine/threonine kinase gene, unc-51-like kinase 4 (ULK4), as a
124                 Overexpression of the serine/threonine kinase GLK/MAP4K3 in human lung cancer is asso
125         We previously showed that the serine/threonine kinase, glycogen synthase kinase, GSK-3alpha/b
126 e specificity of the host pleiotropic serine/threonine kinase GSK3.
127 synthase kinase-3 beta (GSK-3beta), a serine/threonine kinase, has been identified as a potential the
128                                   The serine/threonine kinase HIPK2 functions as a regulator of devel
129 53Ser46(P) by binding and stabilizing serine-threonine kinase HIPK2.
130                                   The serine/threonine kinase IL-1R-associated kinase (IRAK)4 is a cr
131 ibrain (Mnb; also known as Dyrk1A), a serine/threonine kinase implicated in autism spectrum disorder
132 (GSK-3, isoforms alpha and beta) is a serine-threonine kinase implicated in cellular processes.
133  kinase kinase kinase 4 (MAP4K4) is a serine/threonine kinase implicated in the regulation of many bi
134 Protein kinase C (PKC) is a family of serine/threonine kinases implicated in a variety of physiologic
135 e c-Jun N-terminal kinases (JNKs) are serine/threonine kinases implicated in the pathogenesis of vari
136 PKD) is a family of stress-responsive serine/threonine kinases implicated in the regulation of divers
137 the highly overexpressed genes of the serine/threonine kinase in CTCL.
138                 ULK1/Atg1 is the only serine/threonine kinase in the core autophagy pathway and thus
139 ich encodes a type I activin receptor serine/threonine kinase, in 21% of DIPG samples.
140 , we identified PIM1, a non-essential serine-threonine kinase, in a synthetic lethal interaction with
141  a target of casein kinase 2 (CK2), a serine/threonine kinase, in proliferating myoblasts.
142 ycin (TOR), an evolutionary conserved serine/threonine kinase, in the plant defense response.
143 ul stimulus or treatment with the AKT Serine/Threonine kinase inhibitor SH-6 restored splicing factor
144 alciparum exports a family of 18 FIKK serine/threonine kinases into the host cell, suggesting that ph
145                             mTOR is a serine/threonine kinase involved in a variety of cellular activ
146 rylation-regulated kinase DYRK1A is a serine/threonine kinase involved in neuronal differentiation an
147 e-3 (GSK3) are ubiquitously expressed serine-threonine kinases involved in a plethora of functions ra
148 an evolutionarily conserved family of serine/threonine kinases involved in mitosis and meiosis.
149 ously determined that a transmembrane serine/threonine kinase (IreK) and its cognate phosphatase (Ire
150 l-originated protein kinase (TOPK), a serine-threonine kinase is activated by SUV irradiation and inv
151                  The Aurora family of serine/threonine kinases is essential for mitosis.
152                    The specificity of serine/threonine kinases is partly determined by interactions w
153  (CK1alpha), a ubiquitously expressed serine/threonine kinase, is a key negative regulator of oncogen
154                               mTOR, a serine/threonine kinase, is a master regulator of cellular meta
155             Liver kinase B1 (LKB1), a serine/threonine kinase, is a tumor suppressor and metabolic re
156 at casein kinase 1 alpha (Csnk1a1), a serine-threonine kinase, is essential for AML cell survival in
157 se (NLK), an evolutionarily conserved serine/threonine kinase, is highly expressed in the brain, but
158       Protein kinase C (PKC) theta, a serine/threonine kinase, is involved in TH2 cell activation and
159                                Akt, a serine/threonine kinase, is known to increase cell survival by
160 ber of the polo-like kinase family of serine-threonine kinases, is a master regulator of centriole du
161  the phosphorylation by WNKs of other serine-threonine kinases known as SPAK-OSR1.
162 optosis signal-regulating kinase 1, a serine/threonine kinase, leads to improvement in inflammation a
163 kinase (called microtubule-associated serine/threonine kinase like [Mastl] in mammals) is essential f
164 K2 induced spine loss through the serine and threonine kinase LIMK1.
165                     We found that the serine/threonine kinase LKB1 and one of its substrates, AMPK, r
166                       We identify the serine/threonine kinase LKB1 as a key driver of synapse layer e
167                                   The serine/threonine kinase LKB1 has been identified as a potent su
168               We demonstrate that the serine/threonine kinase LKB1 regulates MCU expression, mitochon
169                                   The serine/threonine kinase mammalian/mechanistic target of rapamyc
170 -activated protein kinase-interacting serine-threonine kinases MAP kinase-interacting kinase 1 (Mnk1/
171                  In recent years, the serine/threonine kinase mechanistic target of rapamycin (mTOR)
172 chore attachments is monitored by the serine/threonine kinase monopolar spindle 1 (MPS1).
173          The evolutionarily conserved serine/threonine kinase mTOR (mechanistic target of rapamycin)
174                                   The serine/threonine kinase mTOR participates in growth factor sign
175 nous PTEN-induced kinase 1 (PINK1), a serine/threonine kinase mutated in a recessive forms of Parkins
176 ntify protein kinase C (PKC) gamma, a serine/threonine kinase mutated in the neurodegenerative diseas
177       In this study, we show that the serine/threonine kinase Ndr2 controls integrin-dependent dendri
178                     PRL activates the serine/threonine kinase NEK3, which was reported to enhance bre
179 reen, we identified a mitotic-related serine/threonine kinase, NEK6, as a mediator of androgen-indepe
180 canonical NF-kappaB signaling via the serine/threonine kinase NIK (NF-kappaB-inducing kinase) remains
181 ocated within STK32C, which encodes a serine/threonine kinase, of unknown function.
182  protein kinase (Drak), a cytoplasmic serine/threonine kinase orthologous to the human kinase STK17A,
183  protein kinase (Drak), a cytoplasmic serine/threonine kinase orthologous to the human kinase STK17A.
184 of these binding partners include the serine/threonine kinases, p21-activated kinase 1 (PAK1), apopto
185  determined that d-flow activated the serine/threonine kinase p90RSK, which subsequently phosphorylat
186       Ovaries in flies mutant for the serine/threonine kinase Pak exhibit a novel phenotype, in which
187                                       Serine/threonine kinase PAK1 is activated by estrogen and plays
188                     The p21-activated serine-threonine kinase (PAK1) regulates cell motility and adhe
189        The protein kinase D family of serine/threonine kinases, particularly PKD1, has been implicate
190 The hypoxia-inducible, pro-oncogenic, serine-threonine kinase PIM1 (Proviral Integration site for Mol
191                                   The serine-threonine kinase PINK1 is responsible for recruiting Par
192              PKD is a family of three serine/threonine kinases (PKD-1, -2, and -3) involved in the re
193      We found that RhoA activated the serine-threonine kinases PKN1 and PKN2 that bind and phosphoryl
194                        In eukaryotes, serine/threonine kinases play a central role in antiviral respo
195                Dysregulated oncogenic serine/threonine kinases play a pathological role in diverse fo
196                              IRAK4, a serine/threonine kinase, plays a key role in both inflammation
197                    The Akt protein, a serine/threonine kinase, plays important roles in cell survival
198                       The polo family serine threonine kinase Plk4 has been proposed as a therapeutic
199                We have identified the serine/threonine kinase Polo-like kinase 1 (PLK1) as a host kin
200                  In this context, the serine/threonine kinase, polo-like kinase (PLK1) regulates mult
201 terphase of the cell cycle by NEK7, a serine-threonine kinase previously linked to mitosis.
202 coupled receptor kinase 5 (GRK5) is a serine/threonine kinase previously shown to mediate polymicrobi
203 RIPK1 and RIPK3, a pair of homologous serine/threonine kinases previously implicated in the regulatio
204 echanistic target of rapamycin (mTOR) serine/threonine kinase promotes myelination, but factors that
205 dually suppressed RAF1 proto-oncogene serine/threonine kinase (RAF1)/ERK signaling through the intera
206                    UHMK1 is a nuclear serine/threonine kinase recently implicated in carcinogenesis.
207 ike kinase 1 (ALK1) is an endothelial serine-threonine kinase receptor for bone morphogenetic protein
208          Here, we have identified the serine threonine kinase receptor-associated protein (STRAP) as
209                                Type 1 Serine/Threonine Kinase Receptors (STKR1) transduce a wide spec
210 ng protein kinase (Hipk), a conserved serine-threonine kinase, regulates numerous factors during tiss
211 a B (AURKB) and Aurora C (AURKC), are serine/threonine kinases required for the control of mitosis (A
212 c approach identified PKCtheta as the serine/threonine kinase responsible for alphaPIX serine phospho
213  siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulato
214 RNA virus, triggers activation of the serine-threonine kinases RIP1 and RIP3, which damages mitochond
215                                   The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate
216 g cell-death-inducing activity of the serine/threonine kinase RIPK1.
217          Necroptosis is driven by two serine threonine kinases, RIPK1 (Receptor Interacting Protein K
218 , OGT-mediated O-GlcNAcylation of the serine-threonine kinase RIPK3 on threonine 467 (T467) prevented
219 e translocation and activation of the serine/threonine kinase ROCK1, a downstream target of the RhoA
220 ORC1 activation deploys the ribosomal serine/threonine kinase S6K1 and Polycomb proteins at genomic r
221 fibrosis-relevant tyrosine kinase and serine/threonine kinase signaling pathways.
222 n protein folding, protein synthesis, serine/threonine kinase signalling, glycolysis and gluconeogene
223 on-like (drl-1) gene, which encodes a serine/threonine kinase similar to the mammalian MEKK3 kinase.
224 d by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner
225 d by mass spectrometry identified the serine-threonine kinase SPEG as the only novel binding partner
226 horylated at Thr-50 within the LDS by serine/threonine kinase (STK) 3 and STK4.
227                         Silencing the serine/threonine kinase STK11 (also known as LKB1) in HT-29 cel
228 identify a previously uncharacterized serine/threonine kinase STK19 as a novel NRAS activator.
229 kers, one (rs10937625) located in the serine/threonine kinase STK32B and one (rs17590046) in the tran
230        YAP1 is under the control of a serine-threonine kinase, STK4.
231 o interferes with the activity of the serine/threonine kinase StkP, the central regulator of pneumoco
232              In plants and algae, the serine/threonine kinase STN7/STT7, orthologous protein kinases
233  Trans-membrane signaling involving a serine/threonine kinase (Stt7 in Chlamydomonas reinhardtii) dir
234 dentifying degrader hits based on the serine/threonine kinase TANK-binding kinase 1 (TBK1) and have g
235 n Lm vacuolar rupture, among them the serine/threonine kinase Taok2.
236 enerated Taok3(-/-) mice, lacking the serine/threonine kinase Taok3, and found cell-intrinsic defects
237                                   The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its ho
238 vel gene fusion of MAP3K8, encoding a serine-threonine kinase that activates MEK(3,4).
239                             mTOR is a serine/threonine kinase that acts in two distinct complexes, mT
240            LKB1 is a multi-functional serine/threonine kinase that associates with actin at the cellu
241 ontaining protein kinase 2 (ROCK2), a serine-threonine kinase that can be therapeutically targeted by
242 istic target of rapamycin (mTOR) is a serine-threonine kinase that coordinates nutrient and growth fa
243 apamycin (MTOR) is a highly conserved serine/threonine kinase that critically regulates cell growth,
244 racting protein kinase 1 (RIPK1) is a serine/threonine kinase that dictates whether cells survive or
245 et of rapamycin (mTOR) is an atypical serine/threonine kinase that exerts its main cellular functions
246 et of rapamycin (mTOR) is a conserved serine/threonine kinase that forms two complexes, mTORC1 and mT
247 protein kinase 2 (HIPK2) is a nuclear serine/threonine kinase that functions in development and tumor
248                         Aurora B is a serine/threonine kinase that has been implicated in regulating
249                            GSK-3 is a serine/threonine kinase that has numerous substrates.
250         The HipA toxin functions as a serine/threonine kinase that inhibits cell growth, while the Hi
251 e (AMPK) is an evolutionary conserved serine/threonine kinase that integrates cellular energy status
252 eptor-interacting protein (RIP1) is a serine/threonine kinase that integrates inflammatory and necrop
253                             AMPK is a serine/threonine kinase that is activated by upstream kinases L
254 led that Polo-like kinase 1 (PLK1), a serine/threonine kinase that is essential for cell cycle progre
255 t cyclin-dependent kinase 5 (Cdk5), a serine-threonine kinase that is highly active in postmitotic ne
256 ublecortin-like kinase 1 (DCLK1) is a serine/threonine kinase that is overexpressed in gastrointestin
257  is PIM2, which encodes a prosurvival serine-threonine kinase that phosphorylates and inhibits the pr
258                             Cdc7 is a serine-threonine kinase that phosphorylates components of the p
259 ns was GSG2 (also known as Haspin), a serine/threonine kinase that phosphorylates histone H3 at Thr-3
260 1-like kinase 1 (ULK1) is a conserved serine-threonine kinase that plays a central role in the initia
261 is a highly conserved and pleiotropic serine/threonine kinase that promotes many prosurvival and proi
262 re we identify Stk2, a staphylococcal serine/threonine kinase that provides efficient immunity agains
263 alian target of rapamycin (mTOR) is a serine/threonine kinase that regulates a diverse array of cellu
264 e A (PKA) is a ubiquitously expressed serine/threonine kinase that regulates a variety of cellular fu
265 Tumor progression locus 2 (Tpl2) is a serine-threonine kinase that regulates Th1 differentiation, sec
266 ed kinases (PAKs) are a family of six serine/threonine kinases that act as key effectors of RHO famil
267 OCK1 and ROCK2) are highly homologous serine/threonine kinases that act on substrates associated with
268                                       Serine-threonine kinases that activate NKCC2 have been identifi
269 are a family of constitutively active serine/threonine kinases that are partially redundant and regul
270  LegK1-4 proteins are eukaryotic-like serine/threonine kinases that are translocated by the Dot/Icm t
271 CK) is a member of a diverse group of serine/threonine kinases that feature cytoskeletal association.
272                NEK family kinases are serine/threonine kinases that have been functionally implicated
273 mologous and functionally overlapping serine/threonine kinases that phosphorylate multiple protein su
274 ceptor-associated kinases (IRAKs) are serine/threonine kinases that play critical roles in initiating
275 y of abundant, ubiquitously expressed serine/threonine kinases that regulate multiple cellular proces
276 ho kinases, or ROCKs, are a family of serine-threonine kinases that serve as key downstream effectors
277 e examine the STE20 family of protein serine-threonine kinases to investigate basic mechanisms of sub
278 gnaling pathway consists of conserved serine/threonine kinases to maintain optimal organ sizes.
279           The translocation of Akt, a serine/threonine kinase, to the plasma membrane is a critical s
280                                   The serine-threonine kinase TOR, the Target of Rapamycin, is an imp
281                                   The serine/threonine kinase tumor progression locus 2 (Tpl2, also k
282 through binding and activation of the serine/threonine kinase type II TGF-beta receptor (TbetaRII), w
283  of the essential autophagy initiator serine-threonine kinase ULK1, and increased in the activity upo
284 n of the MTOR complex 1 (RAPTOR), the serine/threonine kinase V-Akt murine thymoma viral oncogene hom
285        Aurora kinases are a family of serine/threonine kinases vital for cell division.
286 pe II (TbetaRII) and type I (TbetaRI) serine/threonine kinases, whereby Smad2 and Smad3 are phosphory
287 kinase 5 (Cdk5) is a proline-directed serine/threonine kinase which is mostly active in the nervous s
288                      AKT and mTOR are serine/threonine kinases which play important roles in cell gro
289  interacts with calmodulin-associated serine/threonine kinase, which is implicated in X-linked mental
290 PAK4 is a member of the PAK family of serine/threonine kinases, which act as effectors for several sm
291                   AMPK is a conserved serine/threonine kinase whose activity maintains cellular energ
292 se II (CaMKII) is a calcium-regulated serine threonine kinase whose functions include regulation of s
293                            ROCK2 is a serine-threonine kinase whose role in lymphomagenesis is unknow
294  protein kinase (AMPK) is a conserved serine/threonine kinase with a critical function in the regulat
295 coupled receptor kinase 2 (GRK2) is a serine/threonine kinase with an important function in the desen
296 racting protein kinase 3 (RIPK3) is a serine/threonine kinase with essential function in necroptosis.
297 Casein kinase 1 alpha (CK1alpha) is a serine/threonine kinase with numerous functions, including regu
298  polo-like kinases (PLK), a family of serine/threonine kinases with well-known roles in cell cycle re
299         Two of these genes encode the serine-threonine kinases WNK1 and WNK4.
300                 One such protein, the serine/threonine kinase YopO (YpkA in Yersinia pestis), uses mo

 
Page Top